Regulus Therapeutics
RGLS
#7017
Rank
A$0.84 B
Marketcap
A$12.17
Share price
0.00%
Change (1 day)
399.44%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: A$0.84 Billion

As of January 2026 Regulus Therapeutics has a market cap of A$0.84 Billion. This makes Regulus Therapeutics the world's 7017th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025A$0.84 B420.11%
2024A$0.16 B326.84%
2023A$37.99 M12.07%
2022A$33.9 M-46.54%
2021A$63.42 M-43.11%
2020A$0.11 B317.29%
2019A$26.71 M129.37%
2018A$11.64 M-91.59%
2017A$0.13 B-16.17%
2016A$0.16 B-73.8%
2015A$0.63 B-34.28%
2014A$0.95 B177.08%
2013A$0.34 B59.38%
2012A$0.21 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
A$148.11 B 17,472.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
A$172.02 B 20,308.78%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$36.89 B 4,277.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$434.80 B 51,483.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
A$70.81 B 8,301.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.21 B-74.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$171.97 B 20,302.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.44 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA